“An inexpensive antidepressant drug (fluvoxamine) has been found to reduce the risk of hospitalization in high-risk adults recently diagnosed with COVID-19 by over 30 percent, according to a study published in The Lancet Global Health.”
Insights for Navigating an Uncertain World
“An inexpensive antidepressant drug (fluvoxamine) has been found to reduce the risk of hospitalization in high-risk adults recently diagnosed with COVID-19 by over 30 percent, according to a study published in The Lancet Global Health.”
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times. View more posts